nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—Cisplatin—esophageal cancer	0.309	1	CbGbCtD
Ramipril—ACE—thoracic aorta—esophageal cancer	0.125	0.437	CbGeAlD
Ramipril—BCHE—diaphragm—esophageal cancer	0.0583	0.203	CbGeAlD
Ramipril—ACE—neck—esophageal cancer	0.0111	0.0385	CbGeAlD
Ramipril—SLC15A1—epithelium—esophageal cancer	0.0105	0.0366	CbGeAlD
Ramipril—SLC15A1—digestive system—esophageal cancer	0.00799	0.0278	CbGeAlD
Ramipril—ACE—epithelium—esophageal cancer	0.00753	0.0262	CbGeAlD
Ramipril—ACE—smooth muscle tissue—esophageal cancer	0.00725	0.0253	CbGeAlD
Ramipril—SLC15A2—bronchus—esophageal cancer	0.00647	0.0225	CbGeAlD
Ramipril—SLC15A2—trachea—esophageal cancer	0.00581	0.0202	CbGeAlD
Ramipril—ACE—digestive system—esophageal cancer	0.00573	0.02	CbGeAlD
Ramipril—BCHE—bronchus—esophageal cancer	0.00548	0.0191	CbGeAlD
Ramipril—BCHE—smooth muscle tissue—esophageal cancer	0.00536	0.0187	CbGeAlD
Ramipril—BCHE—trachea—esophageal cancer	0.00492	0.0171	CbGeAlD
Ramipril—ACE—lung—esophageal cancer	0.00478	0.0167	CbGeAlD
Ramipril—BCHE—digestive system—esophageal cancer	0.00423	0.0147	CbGeAlD
Ramipril—SLC15A2—lung—esophageal cancer	0.00417	0.0145	CbGeAlD
Ramipril—BCHE—lung—esophageal cancer	0.00353	0.0123	CbGeAlD
Ramipril—ACE—lymph node—esophageal cancer	0.00327	0.0114	CbGeAlD
Ramipril—SLC15A2—lymph node—esophageal cancer	0.00285	0.00994	CbGeAlD
Ramipril—BCHE—lymph node—esophageal cancer	0.00242	0.00842	CbGeAlD
Ramipril—Vascular purpura—Capecitabine—esophageal cancer	0.0018	0.00451	CcSEcCtD
Ramipril—Deafness—Capecitabine—esophageal cancer	0.0018	0.00451	CcSEcCtD
Ramipril—Pancytopenia—Cisplatin—esophageal cancer	0.00179	0.0045	CcSEcCtD
Ramipril—Glossitis—Methotrexate—esophageal cancer	0.00179	0.00449	CcSEcCtD
Ramipril—Hepatic failure—Capecitabine—esophageal cancer	0.00179	0.00449	CcSEcCtD
Ramipril—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00178	0.00447	CcSEcCtD
Ramipril—Renal failure acute—Capecitabine—esophageal cancer	0.00174	0.00437	CcSEcCtD
Ramipril—Libido decreased—Capecitabine—esophageal cancer	0.00173	0.00436	CcSEcCtD
Ramipril—Amnesia—Capecitabine—esophageal cancer	0.00171	0.0043	CcSEcCtD
Ramipril—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.0017	0.00428	CcSEcCtD
Ramipril—Atrial fibrillation—Capecitabine—esophageal cancer	0.0017	0.00426	CcSEcCtD
Ramipril—Renal impairment—Capecitabine—esophageal cancer	0.00169	0.00424	CcSEcCtD
Ramipril—Vasculitis—Methotrexate—esophageal cancer	0.00169	0.00424	CcSEcCtD
Ramipril—Purpura—Capecitabine—esophageal cancer	0.00167	0.00419	CcSEcCtD
Ramipril—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00166	0.00416	CcSEcCtD
Ramipril—Arthritis—Capecitabine—esophageal cancer	0.00165	0.00416	CcSEcCtD
Ramipril—Renal failure—Cisplatin—esophageal cancer	0.00165	0.00415	CcSEcCtD
Ramipril—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00165	0.00414	CcSEcCtD
Ramipril—Myocardial infarction—Cisplatin—esophageal cancer	0.00165	0.00414	CcSEcCtD
Ramipril—Cardiac failure—Capecitabine—esophageal cancer	0.00165	0.00414	CcSEcCtD
Ramipril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00164	0.00412	CcSEcCtD
Ramipril—Stomatitis—Cisplatin—esophageal cancer	0.00164	0.00412	CcSEcCtD
Ramipril—Conjunctivitis—Cisplatin—esophageal cancer	0.00163	0.0041	CcSEcCtD
Ramipril—Hyponatraemia—Capecitabine—esophageal cancer	0.00161	0.00405	CcSEcCtD
Ramipril—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00159	0.00401	CcSEcCtD
Ramipril—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00159	0.00399	CcSEcCtD
Ramipril—Blood creatinine increased—Capecitabine—esophageal cancer	0.00151	0.00378	CcSEcCtD
Ramipril—Urine output increased—Methotrexate—esophageal cancer	0.00149	0.00374	CcSEcCtD
Ramipril—Liver function test abnormal—Capecitabine—esophageal cancer	0.00148	0.00373	CcSEcCtD
Ramipril—Connective tissue disorder—Cisplatin—esophageal cancer	0.00148	0.00372	CcSEcCtD
Ramipril—Gynaecomastia—Methotrexate—esophageal cancer	0.00147	0.00371	CcSEcCtD
Ramipril—Abdominal pain upper—Capecitabine—esophageal cancer	0.00147	0.00369	CcSEcCtD
Ramipril—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00147	0.00369	CcSEcCtD
Ramipril—Visual impairment—Cisplatin—esophageal cancer	0.00145	0.00365	CcSEcCtD
Ramipril—Breast disorder—Capecitabine—esophageal cancer	0.00145	0.00365	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00145	0.00364	CcSEcCtD
Ramipril—Gastritis—Capecitabine—esophageal cancer	0.00142	0.00357	CcSEcCtD
Ramipril—Tinnitus—Cisplatin—esophageal cancer	0.00141	0.00353	CcSEcCtD
Ramipril—Flushing—Cisplatin—esophageal cancer	0.0014	0.00352	CcSEcCtD
Ramipril—Influenza—Capecitabine—esophageal cancer	0.00139	0.00349	CcSEcCtD
Ramipril—Dysphagia—Capecitabine—esophageal cancer	0.00139	0.00349	CcSEcCtD
Ramipril—Asthma—Capecitabine—esophageal cancer	0.00139	0.00349	CcSEcCtD
Ramipril—Perindopril—ABCB1—esophageal cancer	0.00137	0.232	CrCbGaD
Ramipril—Bronchospasm—Capecitabine—esophageal cancer	0.00137	0.00343	CcSEcCtD
Ramipril—Photosensitivity—Methotrexate—esophageal cancer	0.00136	0.00342	CcSEcCtD
Ramipril—Polyuria—Methotrexate—esophageal cancer	0.00136	0.00342	CcSEcCtD
Ramipril—Immune system disorder—Cisplatin—esophageal cancer	0.00136	0.00342	CcSEcCtD
Ramipril—Mediastinal disorder—Cisplatin—esophageal cancer	0.00136	0.00342	CcSEcCtD
Ramipril—Sweating increased—Capecitabine—esophageal cancer	0.00135	0.0034	CcSEcCtD
Ramipril—Angina pectoris—Capecitabine—esophageal cancer	0.00135	0.0034	CcSEcCtD
Ramipril—Arrhythmia—Cisplatin—esophageal cancer	0.00135	0.00339	CcSEcCtD
Ramipril—Bronchitis—Capecitabine—esophageal cancer	0.00134	0.00336	CcSEcCtD
Ramipril—Alopecia—Cisplatin—esophageal cancer	0.00133	0.00335	CcSEcCtD
Ramipril—Abdominal discomfort—Capecitabine—esophageal cancer	0.00133	0.00335	CcSEcCtD
Ramipril—Hepatic failure—Methotrexate—esophageal cancer	0.00133	0.00335	CcSEcCtD
Ramipril—Pancytopenia—Capecitabine—esophageal cancer	0.00132	0.00331	CcSEcCtD
Ramipril—Malnutrition—Cisplatin—esophageal cancer	0.00131	0.0033	CcSEcCtD
Ramipril—Erythema—Cisplatin—esophageal cancer	0.00131	0.0033	CcSEcCtD
Ramipril—Neutropenia—Capecitabine—esophageal cancer	0.0013	0.00326	CcSEcCtD
Ramipril—Renal failure acute—Methotrexate—esophageal cancer	0.0013	0.00326	CcSEcCtD
Ramipril—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00129	0.00324	CcSEcCtD
Ramipril—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00127	0.00319	CcSEcCtD
Ramipril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00127	0.00319	CcSEcCtD
Ramipril—Weight increased—Capecitabine—esophageal cancer	0.00126	0.00318	CcSEcCtD
Ramipril—Muscle spasms—Cisplatin—esophageal cancer	0.00126	0.00317	CcSEcCtD
Ramipril—Nateglinide—PTGS1—esophageal cancer	0.00124	0.21	CrCbGaD
Ramipril—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00124	0.00311	CcSEcCtD
Ramipril—Tremor—Cisplatin—esophageal cancer	0.00123	0.00309	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00123	0.00309	CcSEcCtD
Ramipril—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00122	0.00307	CcSEcCtD
Ramipril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00122	0.00307	CcSEcCtD
Ramipril—Ill-defined disorder—Cisplatin—esophageal cancer	0.00122	0.00306	CcSEcCtD
Ramipril—Renal failure—Capecitabine—esophageal cancer	0.00122	0.00306	CcSEcCtD
Ramipril—Myocardial infarction—Capecitabine—esophageal cancer	0.00121	0.00305	CcSEcCtD
Ramipril—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00121	0.00305	CcSEcCtD
Ramipril—Cilazapril—ABCB1—esophageal cancer	0.00121	0.204	CrCbGaD
Ramipril—Lisinopril—ABCB1—esophageal cancer	0.00121	0.204	CrCbGaD
Ramipril—Stomatitis—Capecitabine—esophageal cancer	0.00121	0.00303	CcSEcCtD
Ramipril—Jaundice—Capecitabine—esophageal cancer	0.00121	0.00303	CcSEcCtD
Ramipril—Conjunctivitis—Capecitabine—esophageal cancer	0.0012	0.00303	CcSEcCtD
Ramipril—Urinary tract infection—Capecitabine—esophageal cancer	0.0012	0.00303	CcSEcCtD
Ramipril—Malaise—Cisplatin—esophageal cancer	0.00118	0.00298	CcSEcCtD
Ramipril—Leukopenia—Cisplatin—esophageal cancer	0.00117	0.00295	CcSEcCtD
Ramipril—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00117	0.00294	CcSEcCtD
Ramipril—Epistaxis—Capecitabine—esophageal cancer	0.00117	0.00294	CcSEcCtD
Ramipril—Agranulocytosis—Capecitabine—esophageal cancer	0.00116	0.0029	CcSEcCtD
Ramipril—Convulsion—Cisplatin—esophageal cancer	0.00114	0.00286	CcSEcCtD
Ramipril—Myalgia—Cisplatin—esophageal cancer	0.00112	0.00281	CcSEcCtD
Ramipril—Anxiety—Cisplatin—esophageal cancer	0.00111	0.0028	CcSEcCtD
Ramipril—Hepatitis—Capecitabine—esophageal cancer	0.00111	0.00279	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00111	0.00279	CcSEcCtD
Ramipril—Liver function test abnormal—Methotrexate—esophageal cancer	0.0011	0.00278	CcSEcCtD
Ramipril—Discomfort—Cisplatin—esophageal cancer	0.0011	0.00278	CcSEcCtD
Ramipril—Oedema peripheral—Capecitabine—esophageal cancer	0.00109	0.00275	CcSEcCtD
Ramipril—Connective tissue disorder—Capecitabine—esophageal cancer	0.00109	0.00275	CcSEcCtD
Ramipril—Breast disorder—Methotrexate—esophageal cancer	0.00108	0.00272	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00108	0.00271	CcSEcCtD
Ramipril—Oedema—Cisplatin—esophageal cancer	0.00107	0.00269	CcSEcCtD
Ramipril—Anaphylactic shock—Cisplatin—esophageal cancer	0.00107	0.00269	CcSEcCtD
Ramipril—Visual impairment—Capecitabine—esophageal cancer	0.00107	0.00269	CcSEcCtD
Ramipril—Erythema multiforme—Capecitabine—esophageal cancer	0.00105	0.00264	CcSEcCtD
Ramipril—Nervous system disorder—Cisplatin—esophageal cancer	0.00105	0.00264	CcSEcCtD
Ramipril—Thrombocytopenia—Cisplatin—esophageal cancer	0.00105	0.00264	CcSEcCtD
Ramipril—Tachycardia—Cisplatin—esophageal cancer	0.00105	0.00263	CcSEcCtD
Ramipril—Skin disorder—Cisplatin—esophageal cancer	0.00104	0.00262	CcSEcCtD
Ramipril—Tinnitus—Capecitabine—esophageal cancer	0.00104	0.0026	CcSEcCtD
Ramipril—Hyperhidrosis—Cisplatin—esophageal cancer	0.00104	0.0026	CcSEcCtD
Ramipril—Asthma—Methotrexate—esophageal cancer	0.00103	0.0026	CcSEcCtD
Ramipril—Flushing—Capecitabine—esophageal cancer	0.00103	0.00259	CcSEcCtD
Ramipril—Eosinophilia—Methotrexate—esophageal cancer	0.00102	0.00257	CcSEcCtD
Ramipril—Anorexia—Cisplatin—esophageal cancer	0.00102	0.00257	CcSEcCtD
Ramipril—Pancreatitis—Methotrexate—esophageal cancer	0.00101	0.00255	CcSEcCtD
Ramipril—Immune system disorder—Capecitabine—esophageal cancer	0.001	0.00252	CcSEcCtD
Ramipril—Mediastinal disorder—Capecitabine—esophageal cancer	0.001	0.00252	CcSEcCtD
Ramipril—Hypotension—Cisplatin—esophageal cancer	0.001	0.00252	CcSEcCtD
Ramipril—Arrhythmia—Capecitabine—esophageal cancer	0.000993	0.0025	CcSEcCtD
Ramipril—Abdominal discomfort—Methotrexate—esophageal cancer	0.000991	0.00249	CcSEcCtD
Ramipril—Alopecia—Capecitabine—esophageal cancer	0.000982	0.00247	CcSEcCtD
Ramipril—Pancytopenia—Methotrexate—esophageal cancer	0.000982	0.00247	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000976	0.00245	CcSEcCtD
Ramipril—Mental disorder—Capecitabine—esophageal cancer	0.000974	0.00245	CcSEcCtD
Ramipril—Erythema—Capecitabine—esophageal cancer	0.000968	0.00243	CcSEcCtD
Ramipril—Malnutrition—Capecitabine—esophageal cancer	0.000968	0.00243	CcSEcCtD
Ramipril—Neutropenia—Methotrexate—esophageal cancer	0.000967	0.00243	CcSEcCtD
Ramipril—Paraesthesia—Cisplatin—esophageal cancer	0.000962	0.00242	CcSEcCtD
Ramipril—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000961	0.00241	CcSEcCtD
Ramipril—Dyspnoea—Cisplatin—esophageal cancer	0.000955	0.0024	CcSEcCtD
Ramipril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000952	0.00239	CcSEcCtD
Ramipril—Dysgeusia—Capecitabine—esophageal cancer	0.000948	0.00238	CcSEcCtD
Ramipril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000944	0.00237	CcSEcCtD
Ramipril—Decreased appetite—Cisplatin—esophageal cancer	0.000931	0.00234	CcSEcCtD
Ramipril—Muscle spasms—Capecitabine—esophageal cancer	0.00093	0.00234	CcSEcCtD
Ramipril—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000925	0.00232	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000914	0.0023	CcSEcCtD
Ramipril—Tremor—Capecitabine—esophageal cancer	0.000907	0.00228	CcSEcCtD
Ramipril—Renal failure—Methotrexate—esophageal cancer	0.000906	0.00228	CcSEcCtD
Ramipril—Stomatitis—Methotrexate—esophageal cancer	0.000898	0.00226	CcSEcCtD
Ramipril—Ill-defined disorder—Capecitabine—esophageal cancer	0.000898	0.00226	CcSEcCtD
Ramipril—Conjunctivitis—Methotrexate—esophageal cancer	0.000896	0.00225	CcSEcCtD
Ramipril—Enalapril—ABCB1—esophageal cancer	0.000886	0.15	CrCbGaD
Ramipril—Sweating—Methotrexate—esophageal cancer	0.000884	0.00222	CcSEcCtD
Ramipril—Feeling abnormal—Cisplatin—esophageal cancer	0.000883	0.00222	CcSEcCtD
Ramipril—Malaise—Capecitabine—esophageal cancer	0.000873	0.00219	CcSEcCtD
Ramipril—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000872	0.00219	CcSEcCtD
Ramipril—Epistaxis—Methotrexate—esophageal cancer	0.000869	0.00219	CcSEcCtD
Ramipril—Vertigo—Capecitabine—esophageal cancer	0.000869	0.00219	CcSEcCtD
Ramipril—Syncope—Capecitabine—esophageal cancer	0.000868	0.00218	CcSEcCtD
Ramipril—Leukopenia—Capecitabine—esophageal cancer	0.000866	0.00218	CcSEcCtD
Ramipril—Agranulocytosis—Methotrexate—esophageal cancer	0.00086	0.00216	CcSEcCtD
Ramipril—Palpitations—Capecitabine—esophageal cancer	0.000855	0.00215	CcSEcCtD
Ramipril—Loss of consciousness—Capecitabine—esophageal cancer	0.00085	0.00214	CcSEcCtD
Ramipril—Body temperature increased—Cisplatin—esophageal cancer	0.000847	0.00213	CcSEcCtD
Ramipril—Cough—Capecitabine—esophageal cancer	0.000844	0.00212	CcSEcCtD
Ramipril—Hepatitis—Methotrexate—esophageal cancer	0.000827	0.00208	CcSEcCtD
Ramipril—Chest pain—Capecitabine—esophageal cancer	0.000824	0.00207	CcSEcCtD
Ramipril—Myalgia—Capecitabine—esophageal cancer	0.000824	0.00207	CcSEcCtD
Ramipril—Arthralgia—Capecitabine—esophageal cancer	0.000824	0.00207	CcSEcCtD
Ramipril—Anxiety—Capecitabine—esophageal cancer	0.000821	0.00206	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000818	0.00206	CcSEcCtD
Ramipril—Discomfort—Capecitabine—esophageal cancer	0.000814	0.00205	CcSEcCtD
Ramipril—Dry mouth—Capecitabine—esophageal cancer	0.000806	0.00203	CcSEcCtD
Ramipril—Visual impairment—Methotrexate—esophageal cancer	0.000797	0.002	CcSEcCtD
Ramipril—Confusional state—Capecitabine—esophageal cancer	0.000796	0.002	CcSEcCtD
Ramipril—Oedema—Capecitabine—esophageal cancer	0.00079	0.00198	CcSEcCtD
Ramipril—Hypersensitivity—Cisplatin—esophageal cancer	0.000789	0.00198	CcSEcCtD
Ramipril—Erythema multiforme—Methotrexate—esophageal cancer	0.000782	0.00197	CcSEcCtD
Ramipril—Shock—Capecitabine—esophageal cancer	0.000777	0.00195	CcSEcCtD
Ramipril—Nervous system disorder—Capecitabine—esophageal cancer	0.000774	0.00195	CcSEcCtD
Ramipril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000773	0.00194	CcSEcCtD
Ramipril—Tinnitus—Methotrexate—esophageal cancer	0.000771	0.00194	CcSEcCtD
Ramipril—Tachycardia—Capecitabine—esophageal cancer	0.000771	0.00194	CcSEcCtD
Ramipril—Asthenia—Cisplatin—esophageal cancer	0.000769	0.00193	CcSEcCtD
Ramipril—Skin disorder—Capecitabine—esophageal cancer	0.000767	0.00193	CcSEcCtD
Ramipril—Hyperhidrosis—Capecitabine—esophageal cancer	0.000763	0.00192	CcSEcCtD
Ramipril—Anorexia—Capecitabine—esophageal cancer	0.000753	0.00189	CcSEcCtD
Ramipril—Immune system disorder—Methotrexate—esophageal cancer	0.000747	0.00188	CcSEcCtD
Ramipril—Mediastinal disorder—Methotrexate—esophageal cancer	0.000746	0.00187	CcSEcCtD
Ramipril—Hypotension—Capecitabine—esophageal cancer	0.000738	0.00185	CcSEcCtD
Ramipril—Diarrhoea—Cisplatin—esophageal cancer	0.000733	0.00184	CcSEcCtD
Ramipril—Alopecia—Methotrexate—esophageal cancer	0.000731	0.00184	CcSEcCtD
Ramipril—Mental disorder—Methotrexate—esophageal cancer	0.000725	0.00182	CcSEcCtD
Ramipril—Erythema—Methotrexate—esophageal cancer	0.00072	0.00181	CcSEcCtD
Ramipril—Malnutrition—Methotrexate—esophageal cancer	0.00072	0.00181	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000719	0.00181	CcSEcCtD
Ramipril—Insomnia—Capecitabine—esophageal cancer	0.000714	0.0018	CcSEcCtD
Ramipril—Paraesthesia—Capecitabine—esophageal cancer	0.000709	0.00178	CcSEcCtD
Ramipril—Dysgeusia—Methotrexate—esophageal cancer	0.000705	0.00177	CcSEcCtD
Ramipril—Dyspnoea—Capecitabine—esophageal cancer	0.000704	0.00177	CcSEcCtD
Ramipril—Dyspepsia—Capecitabine—esophageal cancer	0.000695	0.00175	CcSEcCtD
Ramipril—Decreased appetite—Capecitabine—esophageal cancer	0.000686	0.00173	CcSEcCtD
Ramipril—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000682	0.00171	CcSEcCtD
Ramipril—Vomiting—Cisplatin—esophageal cancer	0.000681	0.00171	CcSEcCtD
Ramipril—Fatigue—Capecitabine—esophageal cancer	0.000681	0.00171	CcSEcCtD
Ramipril—Rash—Cisplatin—esophageal cancer	0.000675	0.0017	CcSEcCtD
Ramipril—Constipation—Capecitabine—esophageal cancer	0.000675	0.0017	CcSEcCtD
Ramipril—Dermatitis—Cisplatin—esophageal cancer	0.000675	0.0017	CcSEcCtD
Ramipril—Ill-defined disorder—Methotrexate—esophageal cancer	0.000668	0.00168	CcSEcCtD
Ramipril—Feeling abnormal—Capecitabine—esophageal cancer	0.000651	0.00164	CcSEcCtD
Ramipril—Malaise—Methotrexate—esophageal cancer	0.00065	0.00163	CcSEcCtD
Ramipril—Vertigo—Methotrexate—esophageal cancer	0.000647	0.00163	CcSEcCtD
Ramipril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000646	0.00162	CcSEcCtD
Ramipril—Leukopenia—Methotrexate—esophageal cancer	0.000645	0.00162	CcSEcCtD
Ramipril—Nausea—Cisplatin—esophageal cancer	0.000636	0.0016	CcSEcCtD
Ramipril—Cough—Methotrexate—esophageal cancer	0.000629	0.00158	CcSEcCtD
Ramipril—Urticaria—Capecitabine—esophageal cancer	0.000627	0.00158	CcSEcCtD
Ramipril—Abdominal pain—Capecitabine—esophageal cancer	0.000624	0.00157	CcSEcCtD
Ramipril—Body temperature increased—Capecitabine—esophageal cancer	0.000624	0.00157	CcSEcCtD
Ramipril—Convulsion—Methotrexate—esophageal cancer	0.000624	0.00157	CcSEcCtD
Ramipril—Chest pain—Methotrexate—esophageal cancer	0.000613	0.00154	CcSEcCtD
Ramipril—Arthralgia—Methotrexate—esophageal cancer	0.000613	0.00154	CcSEcCtD
Ramipril—Myalgia—Methotrexate—esophageal cancer	0.000613	0.00154	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000609	0.00153	CcSEcCtD
Ramipril—Discomfort—Methotrexate—esophageal cancer	0.000606	0.00152	CcSEcCtD
Ramipril—Confusional state—Methotrexate—esophageal cancer	0.000593	0.00149	CcSEcCtD
Ramipril—Anaphylactic shock—Methotrexate—esophageal cancer	0.000588	0.00148	CcSEcCtD
Ramipril—Hypersensitivity—Capecitabine—esophageal cancer	0.000582	0.00146	CcSEcCtD
Ramipril—Nervous system disorder—Methotrexate—esophageal cancer	0.000577	0.00145	CcSEcCtD
Ramipril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000576	0.00145	CcSEcCtD
Ramipril—Skin disorder—Methotrexate—esophageal cancer	0.000571	0.00144	CcSEcCtD
Ramipril—Hyperhidrosis—Methotrexate—esophageal cancer	0.000568	0.00143	CcSEcCtD
Ramipril—Asthenia—Capecitabine—esophageal cancer	0.000567	0.00142	CcSEcCtD
Ramipril—Anorexia—Methotrexate—esophageal cancer	0.00056	0.00141	CcSEcCtD
Ramipril—Pruritus—Capecitabine—esophageal cancer	0.000559	0.0014	CcSEcCtD
Ramipril—Hypotension—Methotrexate—esophageal cancer	0.000549	0.00138	CcSEcCtD
Ramipril—Diarrhoea—Capecitabine—esophageal cancer	0.00054	0.00136	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000536	0.00135	CcSEcCtD
Ramipril—Insomnia—Methotrexate—esophageal cancer	0.000532	0.00134	CcSEcCtD
Ramipril—Paraesthesia—Methotrexate—esophageal cancer	0.000528	0.00133	CcSEcCtD
Ramipril—Dyspnoea—Methotrexate—esophageal cancer	0.000524	0.00132	CcSEcCtD
Ramipril—Somnolence—Methotrexate—esophageal cancer	0.000523	0.00131	CcSEcCtD
Ramipril—Dizziness—Capecitabine—esophageal cancer	0.000522	0.00131	CcSEcCtD
Ramipril—Dyspepsia—Methotrexate—esophageal cancer	0.000517	0.0013	CcSEcCtD
Ramipril—Decreased appetite—Methotrexate—esophageal cancer	0.000511	0.00128	CcSEcCtD
Ramipril—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000508	0.00128	CcSEcCtD
Ramipril—Fatigue—Methotrexate—esophageal cancer	0.000507	0.00127	CcSEcCtD
Ramipril—Vomiting—Capecitabine—esophageal cancer	0.000502	0.00126	CcSEcCtD
Ramipril—Rash—Capecitabine—esophageal cancer	0.000498	0.00125	CcSEcCtD
Ramipril—Dermatitis—Capecitabine—esophageal cancer	0.000497	0.00125	CcSEcCtD
Ramipril—Headache—Capecitabine—esophageal cancer	0.000495	0.00124	CcSEcCtD
Ramipril—Feeling abnormal—Methotrexate—esophageal cancer	0.000484	0.00122	CcSEcCtD
Ramipril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000481	0.00121	CcSEcCtD
Ramipril—Nausea—Capecitabine—esophageal cancer	0.000469	0.00118	CcSEcCtD
Ramipril—Urticaria—Methotrexate—esophageal cancer	0.000467	0.00117	CcSEcCtD
Ramipril—Body temperature increased—Methotrexate—esophageal cancer	0.000465	0.00117	CcSEcCtD
Ramipril—Abdominal pain—Methotrexate—esophageal cancer	0.000465	0.00117	CcSEcCtD
Ramipril—Hypersensitivity—Methotrexate—esophageal cancer	0.000433	0.00109	CcSEcCtD
Ramipril—Asthenia—Methotrexate—esophageal cancer	0.000422	0.00106	CcSEcCtD
Ramipril—Pruritus—Methotrexate—esophageal cancer	0.000416	0.00105	CcSEcCtD
Ramipril—Diarrhoea—Methotrexate—esophageal cancer	0.000402	0.00101	CcSEcCtD
Ramipril—Dizziness—Methotrexate—esophageal cancer	0.000389	0.000977	CcSEcCtD
Ramipril—Vomiting—Methotrexate—esophageal cancer	0.000374	0.00094	CcSEcCtD
Ramipril—Rash—Methotrexate—esophageal cancer	0.000371	0.000932	CcSEcCtD
Ramipril—Dermatitis—Methotrexate—esophageal cancer	0.00037	0.000931	CcSEcCtD
Ramipril—Headache—Methotrexate—esophageal cancer	0.000368	0.000926	CcSEcCtD
Ramipril—Nausea—Methotrexate—esophageal cancer	0.000349	0.000878	CcSEcCtD
